Researchers at Moorfields Eye Hospital and the University College London have used artificial intelligence technology to pinpoint markers within eye scans and identify the existence of Parkinson’s disease an average of seven years before clinical symptoms manifest.
The research, published in…
From: www.healthcareitnews.com – Read more
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
